| 0.2709 0.024 (9.81%) | 06-04 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.39 | 1-year : | 0.46 |
| Resists | First : | 0.34 | Second : | 0.4 |
| Pivot price | 0.26  |
|||
| Supports | First : | 0.24 | Second : | 0.2 |
| MAs | MA(5) : | 0.25 |
MA(20) : | 0.28 |
| MA(100) : | 0.36 |
MA(250) : | 0.57 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 19.3 |
D(3) : | 12 |
| RSI | RSI(14): 44.1 |
|||
| 52-week | High : | 1.32 | Low : | 0.24 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ COSM ] has closed below upper band by 43.2%. Bollinger Bands are 23% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.28 - 0.28 | 0.28 - 0.28 |
| Low: | 0.25 - 0.25 | 0.25 - 0.25 |
| Close: | 0.27 - 0.27 | 0.27 - 0.28 |
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Thu, 04 Jun 2026
Cosmos Health expands Sky Premium Life to all 27 EU states By Investing.com - Investing.com Australia
Thu, 04 Jun 2026
Vitamins brand Sky Premium Life goes on sale in all 27 EU countries - Stock Titan
Thu, 04 Jun 2026
Cosmos Health (COSM) to Explore Monetization of Non-Core Assets - GuruFocus
Thu, 04 Jun 2026
Cosmos Health explores sale of non-core assets worth $20M By Investing.com - Investing.com India
Thu, 04 Jun 2026
Cosmos Health Inc. Identifies $20 Million in Non-Core Assets for Potential Monetization - Quiver Quantitative
Thu, 04 Jun 2026
Cosmos Health real estate valued above its market cap - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 54 (M) |
| Shares Float | 40 (M) |
| Held by Insiders | 29 (%) |
| Held by Institutions | 5.6 (%) |
| Shares Short | 977 (K) |
| Shares Short P.Month | 510 (K) |
| EPS | -0.67 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.36 |
| Profit Margin | -30.5 % |
| Operating Margin | -12.2 % |
| Return on Assets (ttm) | -18.8 % |
| Return on Equity (ttm) | -92.4 % |
| Qtrly Rev. Growth | 30.7 % |
| Gross Profit (p.s.) | 0.13 |
| Sales Per Share | 1.27 |
| EBITDA (p.s.) | -0.31 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -9 (M) |
| Levered Free Cash Flow | -11 (M) |
| PE Ratio | -0.42 |
| PEG Ratio | 0 |
| Price to Book value | 0.76 |
| Price to Sales | 0.21 |
| Price to Cash Flow | -1.61 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|